Symbiosis Completes Qualification of Automated Fill/Finish Line at New Commercial Facility in Scotland

Symbiosis Pharmaceutical Services (Symbiosis), a global contract manufacturing organisation (CMO) specialising in the sterile manufacture of injectable d...

October 01, 2025 | Wednesday | News
Greenwich LifeSciences Expands Phase III FLAMINGO-01 Breast Cancer Trial to Portugal

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-1...

October 01, 2025 | Wednesday | News
Amneal Pharmaceuticals Submits BLA for Omalizumab Biosimilar to XOLAIR®, Developed with Kashiv BioSciences

Amneal Pharmaceuticals, Inc.announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for a propos...

September 30, 2025 | Tuesday | News
Harrow to Acquire Melt Pharmaceuticals, Advancing Non-Opioid, Needle-Free Sedation Therapy MELT-300

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, announced that it has entered into an ag...

September 30, 2025 | Tuesday | News
Kindeva Opens New UK Headquarters at Charnwood Campus to Advance Sustainable Inhaler Propellants

Kindeva, a global CDMO and drug delivery expert, has officially opened its new UK headquarters at Charnwood Campus Science Innovation and Technology Park...

September 19, 2025 | Friday | News
Sanofi’s Brivekimig Demonstrates Positive Phase 2a Results in Moderate-to-Severe Hidradenitis Suppurativa

In phase 2a study, brivekimig led to clinically meaningful improvements in primary and key secondary endpoints in biologic-naïve patients compared...

September 18, 2025 | Thursday | News
VintaBio Files Patents for Breakthrough Biotherapeutics Manufacturing Platform That Slashes Development Timelines

Proprietary process reduces development timelines from 18 months to as little as 3, eliminates reliance on traditional plastic flatware, and offers rap...

September 17, 2025 | Wednesday | News
Allot and SnapLogic Launch AI Agent to Tackle Health Inequalities Using Advanced Data Integration

New AI agent turns complex healthcare and environmental data into actionable insights for pharmaceutical teams. SnapLogic, the Agentic Integra...

September 17, 2025 | Wednesday | News
NurExone’s U.S. Subsidiary Exo-Top Plans First Commercial Exosome Production Facility in Indianapolis

  NurExone Biologic Inc., a biopharmaceutical innovator in exosome-based regenerative therapies, is pleased to announce that its U.S. subsidiary, Exo...

September 17, 2025 | Wednesday | News
Parexel and Paradigm Health Form Strategic Partnership to Transform Clinical Trial Execution with AI-Driven Platform

Parexel, a leading global clinical research organization (CRO), and Paradigm Health, a company rebuilding the clinical research ecosystem, announced a st...

September 16, 2025 | Tuesday | News
Thermo Fisher Scientific Launches Olink® Target 48 Neurodegeneration Panel for Absolute Quantification of Key Biomarkers

Targeted proteomics panel delivers absolute quantification of key and emerging biomarkers in one scalable assay Thermo Fisher Scientific Inc., the world...

September 16, 2025 | Tuesday | News
Lupin Secures U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension with 180-Day CGT Exclusivity

Global pharma major Lupin Limited  announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Ab...

September 12, 2025 | Friday | News
Cascade Bio Secures $6M to Power Cell-Free Biomanufacturing Revolution

Cascade Bio, an industrial biotech company enabling enzyme-based processes, has secured $6M to accelerate the shift from petrochemicals to biomanufacturi...

September 10, 2025 | Wednesday | News
Enzene Inaugurates First U.S. Biomanufacturing Facility with Governor Phil Murphy in New Jersey

  Governor Phil Murphy officially inaugurated the state-of-the-art biomanufacturing facility of Enzene, a leading global continuously innovative deve...

September 10, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close